STELLA PHARMA CORPORATION
ステラファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4888
FY2025 · 2026-03-31
| Gross margin | 86.3% |
| Operating margin | -231.6% |
| Net margin | -241.5% |
| Return on equity | — |
| Return on assets | -17.4% |
| Revenue growth (YoY) | -66.4% |
| EPS (basic) | ¥-22.95 |
| EPS growth (YoY) | — |
| Current ratio | 16.75x |
| Equity ratio | 54.1% |
| Book value / share | ¥71.33 |
| Free cash flow | -345 M |